Literature DB >> 1722315

De novo chromosome formation in rodent cells.

T Praznovszky1, J Keresö, V Tubak, I Cserpán, K Fátyol, G Hadlaczky.   

Abstract

A hybrid cell line was produced by the fusion of an EC3/7 mouse cell with a Chinese hamster ovary cell. The EC3/7 cell carries a dicentric chromosome with a functional marker centromere. This marker centromere contains human, lambda, and bacterial vector DNA sequences and a dominant selectable gene (aminoglycoside 3'-phosphotransferase type II; neo). In the hybrid, the marker centromere separated from the dicentric chromosome and formed a full-sized chromosome (lambda neo). The newly formed chromosome is stable, even under nonselective culture conditions. This functional chromosome, which is the result of an amplification process, is composed of seven large, different-sized amplicons. Each amplicon contains multiple copies of human, lambda, neo, and mouse telomeric DNA sequences. Individual amplicons are separated from each other by mouse major satellite DNA sequences. The marker centromere was localized to a terminal amplicon by anticentromere immunostaining. The number of amplicons in the newly formed chromosome is remarkably consistent. This finding suggests that the length of the newly formed chromosome is highly constrained.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722315      PMCID: PMC53069          DOI: 10.1073/pnas.88.24.11042

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

Review 1.  Recent progress in understanding mechanisms of mammalian DNA amplification.

Authors:  G R Stark; M Debatisse; E Giulotto; G M Wahl
Journal:  Cell       Date:  1989-06-16       Impact factor: 41.582

2.  Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells.

Authors:  K A Smith; P A Gorman; M B Stark; R P Groves; G R Stark
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

3.  Conservation of the human telomere sequence (TTAGGG)n among vertebrates.

Authors:  J Meyne; R L Ratliff; R K Moyzis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Distribution of non-telomeric sites of the (TTAGGG)n telomeric sequence in vertebrate chromosomes.

Authors:  J Meyne; R J Baker; H H Hobart; T C Hsu; O A Ryder; O G Ward; J E Wiley; D H Wurster-Hill; T L Yates; R K Moyzis
Journal:  Chromosoma       Date:  1990-04       Impact factor: 4.316

5.  Decondensation of constitutive heterochromatin in L cell chromosomes by a benzimidazole compound ("33258 Hoechst").

Authors:  I Hilwig; A Gropp
Journal:  Exp Cell Res       Date:  1973-10       Impact factor: 3.905

6.  The structure of a subterminal repeated sequence present on many human chromosomes.

Authors:  S Cross; J Lindsey; J Fantes; S McKay; N McGill; H Cooke
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

7.  Centromere formation in mouse cells cotransformed with human DNA and a dominant marker gene.

Authors:  G Hadlaczky; T Praznovszky; I Cserpán; J Keresö; M Péterfy; I Kelemen; E Atalay; A Szeles; J Szelei; V Tubak
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

8.  Sequence organization and cytological localization of the minor satellite of mouse.

Authors:  A K Wong; J B Rattner
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

9.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Authors:  D Pinkel; T Straume; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  The multicopy appearance of a large inverted duplication and the sequence at the inversion joint suggest a new model for gene amplification.

Authors:  O Hyrien; M Debatisse; G Buttin; B R de Saint Vincent
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  8 in total

1.  De novo chromosome formations by large-scale amplification of the centromeric region of mouse chromosomes.

Authors:  J Keresö; T Praznovszky; I Cserpán; K Fodor; R Katona; E Csonka; K Fátyol; G Holló; A Szeles; A R Ross; A T Sumner; A A Szalay; G Hadlaczky
Journal:  Chromosome Res       Date:  1996-04       Impact factor: 5.239

2.  Human artificial chromosomes for future biomedicine.

Authors:  Robert L Katona
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Replication of yeast DNA and novel chromosome formation in mouse cells.

Authors:  A McGuigan; C Huxley
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

Review 4.  De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications.

Authors:  Robert L Katona
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

5.  A mammalian artificial chromosome engineering system (ACE System) applicable to biopharmaceutical protein production, transgenesis and gene-based cell therapy.

Authors:  Michael Lindenbaum; Ed Perkins; Erika Csonka; Elena Fleming; Lisa Garcia; Amy Greene; Lindsay Gung; Gyula Hadlaczky; Edmond Lee; Josephine Leung; Neil MacDonald; Alexisann Maxwell; Kathleen Mills; Diane Monteith; Carl F Perez; Joan Shellard; Sandy Stewart; Tom Stodola; Dana Vandenborre; Sandy Vanderbyl; Harry C Ledebur
Journal:  Nucleic Acids Res       Date:  2004-12-07       Impact factor: 16.971

6.  Characterization of the Nicotiana tabacum L. genome by molecular cytogenetics.

Authors:  A Kenton; A S Parokonny; Y Y Gleba; M D Bennett
Journal:  Mol Gen Genet       Date:  1993-08

7.  Artificial chromosome formation in maize (Zea mays L.).

Authors:  Evgueni V Ananiev; Chengcang Wu; Mark A Chamberlin; Sergei Svitashev; Chris Schwartz; William Gordon-Kamm; Scott Tingey
Journal:  Chromosoma       Date:  2008-11-18       Impact factor: 4.316

8.  Novel method to load multiple genes onto a mammalian artificial chromosome.

Authors:  Anna Tóth; Katalin Fodor; Tünde Praznovszky; Vilmos Tubak; Andor Udvardy; Gyula Hadlaczky; Robert L Katona
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.